CRVS logo

Corvus Pharmaceuticals, Inc.


CRVS: Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant.


Show CRVS Financials

Consumer Interest
SEC Filings

Recent trades of CRVS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by CRVS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Pharmaceutical formulations Mar. 08, 2022
  • Patent Title: Compounds and methods for modulating adenosine a2b receptor and adenosine a2a receptor Feb. 22, 2022
  • Patent Title: Methods of treating cancer Jun. 22, 2021
  • Patent Title: Compounds and methods for modulating interleukin-2-inducible t-cell kinase May. 18, 2021
  • Patent Title: Methods of treating cancer Feb. 09, 2021
  • Patent Title: Compounds and methods for modulating bruton's tyrosine kinase Dec. 22, 2020
  • Patent Title: Humanized anti-cd73 antibodies Nov. 03, 2020
  • Patent Title: Anti-cd73 antibodies Oct. 06, 2020
  • Patent Title: Processes for making triazolo[4,5d] pyramidine derivatives and intermediates thereof May. 19, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of CRVS in WallStreetBets Daily Discussion


Recent insights relating to CRVS

CNBC Recommendations

Recent picks made for CRVS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRVS

Corporate Flights

Flights by private jets registered to CRVS